Somatic gain-of-function mutations of PTPN11 have been linked to several hematological malignancies, such as juvenile myelomonocytic leukemia (JMML) [17], [18], and to several types of human solid malignancies [19], [20], [21]. The gene discussed is PTPN11; the disease is juvenile myelomonocytic leukemia.